{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T21:42:47Z","timestamp":1788212567350,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1479-5876-12-182","type":"journal-article","created":{"date-parts":[[2014,6,25]],"date-time":"2014-06-25T03:02:46Z","timestamp":1403665366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Metallothionein III (MT3) is a putative tumor suppressor gene that is frequently inactivated in pediatric acute myeloid leukemia by promoter hypermethylation"],"prefix":"10.1186","volume":"12","author":[{"given":"Yan-Fang","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Xiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Heng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Yan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na-Na","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Juan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Chao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Fang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Yun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,25]]},"reference":[{"key":"1886_CR1","first-page":"53","volume":"14","author":"FR Appelbaum","year":"2000","unstructured":"Appelbaum FR, Baer MR, Carabasi MH, Coutre SE, Erba HP, Estey E, Glenn MJ, Kraut EH, Maslak P, Millenson M, Miller CB, Saba HI, Stone R, Tallman MS: NCCN practice guidelines for Acute Myelogenous Leukemia. Oncology (Williston Park). 2000, 14: 53-61.","journal-title":"Oncology (Williston Park)"},{"key":"1886_CR2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1182\/blood.V74.1.395.395","volume":"74","author":"GF Sanz","year":"1989","unstructured":"Sanz GF, Sanz MA, Vallespi T, Canizo MC, Torrabadella M, Garcia S, Irriguible D, San Miguel JF: Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood. 1989, 74: 395-408.","journal-title":"Blood"},{"key":"1886_CR3","doi-asserted-by":"publisher","first-page":"21477","DOI":"10.1074\/jbc.M702287200","volume":"282","author":"I Basu","year":"2007","unstructured":"Basu I, Cordovano G, Das I, Belbin TJ, Guha C, Schramm VL: A transition state analogue of 5\u2032-methylthioadenosine phosphorylase induces apoptosis in head and neck cancers. J Biol Chem. 2007, 282: 21477-21486.","journal-title":"J Biol Chem"},{"key":"1886_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/gb-2002-3-2-reviews1003","volume":"3","author":"MR Mann","year":"2002","unstructured":"Mann MR, Bartolomei MS: Epigenetic reprogramming in the mammalian embryo: struggle of the clones. Genome Biol. 2002, 3: 2-REVIEWS1003","journal-title":"Genome Biol"},{"key":"1886_CR5","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1158\/0008-5472.CAN-06-1681","volume":"67","author":"S Agrawal","year":"2007","unstructured":"Agrawal S, Unterberg M, Koschmieder S, ZurStadt U, Brunnberg U, Verbeek W, Buchner T, Berdel WE, Serve H, Muller-Tidow C: DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia. Cancer Res. 2007, 67: 1370-1377.","journal-title":"Cancer Res"},{"key":"1886_CR6","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s12013-013-9555-2","volume":"67","author":"H Akhavan-Niaki","year":"2013","unstructured":"Akhavan-Niaki H, Samadani AA: DNA methylation and cancer development: molecular mechanism. Cell Biochem Biophys. 2013, 67: 501-513.","journal-title":"Cell Biochem Biophys"},{"key":"1886_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1126\/science.1083558","volume":"300","author":"F Gaudet","year":"2003","unstructured":"Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW, Leonhardt H, Jaenisch R: Induction of tumors in mice by genomic hypomethylation. Science. 2003, 300: 489-492.","journal-title":"Science"},{"key":"1886_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/25779","volume":"395","author":"RZ Chen","year":"1998","unstructured":"Chen RZ, Pettersson U, Beard C, Jackson-Grusby L, Jaenisch R: DNA hypomethylation leads to elevated mutation rates. Nature. 1998, 395: 89-93.","journal-title":"Nature"},{"key":"1886_CR9","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/clinchem\/47.7.1183","volume":"47","author":"J Worm","year":"2001","unstructured":"Worm J, Aggerholm A, Guldberg P: In-tube DNA methylation profiling by fluorescence melting curve analysis. Clin Chem. 2001, 47: 1183-1189.","journal-title":"Clin Chem"},{"key":"1886_CR10","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/sj.leu.2402087","volume":"15","author":"CL Willman","year":"2001","unstructured":"Willman CL: Targeted AML therapy: new biologic paradigms and therapeutic opportunities. Leukemia. 2001, 15: 690-694.","journal-title":"Leukemia"},{"key":"1886_CR11","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1182\/blood.V97.9.2823","volume":"97","author":"M Toyota","year":"2001","unstructured":"Toyota M, Kopecky KJ, Toyota MO, Jair KW, Willman CL, Issa JP: Methylation profiling in acute myeloid leukemia. Blood. 2001, 97: 2823-2829.","journal-title":"Blood"},{"key":"1886_CR12","first-page":"4715","volume":"32","author":"R Miftakhova","year":"2012","unstructured":"Miftakhova R, Sandberg T, Hedblom A, Nevzorova T, Persson JL, Bredberg A: DNA methylation in ATRA-treated leukemia cell lines lacking a PML-RAR chromosome translocation. Anticancer Res. 2012, 32: 4715-4722.","journal-title":"Anticancer Res"},{"key":"1886_CR13","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1111\/febs.12673","volume":"281","author":"L Fu","year":"2013","unstructured":"Fu L, Huang W, Jing Y, Jiang M, Zhao Y, Shi J, Huang S, Xue X, Zhang Q, Tang J, Dou L, Wang L, Nervi C, Li Y, Yu L: AML1-ETO triggers epigenetic activation of early growth response gene l, inducing apoptosis in t (8;21) acute myeloid leukemia. Febs J. 2013, 281: 1123-1131.","journal-title":"Febs J"},{"key":"1886_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.it.2012.06.002","volume":"33","author":"AJ Deshpande","year":"2012","unstructured":"Deshpande AJ, Bradner J, Armstrong SA: Chromatin modifications as therapeutic targets in MLL-rearranged leukemia. Trends Immunol. 2012, 33: 563-570.","journal-title":"Trends Immunol"},{"key":"1886_CR15","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1182\/asheducation-2011.1.354","volume":"2011","author":"KM Bernt","year":"2011","unstructured":"Bernt KM, Armstrong SA: Targeting epigenetic programs in MLL-rearranged leukemias. Hematology Am Soc Hematol Educ Program. 2011, 2011: 354-360.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"1886_CR16","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00277-006-0148-7","volume":"85","author":"Y Tabe","year":"2006","unstructured":"Tabe Y, Konopleva M, Kondo Y, Contractor R, Jin L, Ruvolo V, Tsutsumi-Ishii Y, Miyake K, Miyake N, Ohsaka A, Nagaoka I, Issa JP, Andreeff M: PML-RARalpha and AML1-ETO translocations are rarely associated with methylation of the RARbeta2 promoter. Ann Hematol. 2006, 85: 689-704.","journal-title":"Ann Hematol"},{"key":"1886_CR17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/leu.2013.336","volume":"28","author":"T Haferlach","year":"2014","unstructured":"Haferlach T, Nagata Y, Grossmann V, Okuno Y, Bacher U, Nagae G, Schnittger S, Sanada M, Kon A, Alpermann T, Yoshida K, Roller A, Nadarajah N, Shiraishi Y, Shiozawa Y, Chiba K, Tanaka H, Koeffler HP, Klein HU, Dugas M, Aburatani H, Kohlmann A, Miyano S, Haferlach C, Kern W, Ogawa S: Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia. 2014, 28: 241-247.","journal-title":"Leukemia"},{"key":"1886_CR18","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/leu.2011.326","volume":"26","author":"S Weissmann","year":"2012","unstructured":"Weissmann S, Alpermann T, Grossmann V, Kowarsch A, Nadarajah N, Eder C, Dicker F, Fasan A, Haferlach C, Haferlach T, Kern W, Schnittger S, Kohlmann A: Landscape of TET2 mutations in acute myeloid leukemia. Leukemia. 2012, 26: 934-942.","journal-title":"Leukemia"},{"key":"1886_CR19","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.brainresbull.2005.07.012","volume":"67","author":"A Ajjimaporn","year":"2005","unstructured":"Ajjimaporn A, Swinscoe J, Shavali S, Govitrapong P, Ebadi M: Metallothionein provides zinc-mediated protective effects against methamphetamine toxicity in SK-N-SH cells. Brain Res Bull. 2005, 67: 466-475.","journal-title":"Brain Res Bull"},{"key":"1886_CR20","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1111\/j.1742-4658.2010.07718.x","volume":"277","author":"C Howells","year":"2010","unstructured":"Howells C, West AK, Chung RS: Neuronal growth-inhibitory factor (metallothionein-3): evaluation of the biological function of growth-inhibitory factor in the injured and neurodegenerative brain. Febs J. 2010, 277: 2931-2939.","journal-title":"Febs J"},{"key":"1886_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1590\/S0004-282X2011000100020","volume":"69","author":"F Ma","year":"2011","unstructured":"Ma F, Wang H, Chen B, Wang F, Xu H: Metallothionein 3 attenuated the apoptosis of neurons in the CA1 region of the hippocampus in the senescence-accelerated mouse\/PRONE8 (SAMP8). Arq Neuropsiquiatr. 2011, 69: 105-111.","journal-title":"Arq Neuropsiquiatr"},{"key":"1886_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S0969-9961(03)00015-9","volume":"13","author":"J Carrasco","year":"2003","unstructured":"Carrasco J, Penkowa M, Giralt M, Camats J, Molinero A, Campbell IL, Palmiter RD, Hidalgo J: Role of metallothionein-III following central nervous system damage. Neurobiol Dis. 2003, 13: 22-36.","journal-title":"Neurobiol Dis"},{"key":"1886_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1756-6606-3-30","volume":"3","author":"SJ Lee","year":"2010","unstructured":"Lee SJ, Koh JY: Roles of zinc and metallothionein-3 in oxidative stress-induced lysosomal dysfunction, cell death, and autophagy in neurons and astrocytes. Mol Brain. 2010, 3: 30-","journal-title":"Mol Brain"},{"key":"1886_CR24","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.1158\/0008-5472.CAN-05-4268","volume":"66","author":"AM Lowy","year":"2006","unstructured":"Lowy AM, Clements WM, Bishop J, Kong L, Bonney T, Sisco K, Aronow B, Fenoglio-Preiser C, Groden J: beta-Catenin\/Wnt signaling regulates expression of the membrane type 3 matrix metalloproteinase in gastric cancer. Cancer Res. 2006, 66: 4734-4741.","journal-title":"Cancer Res"},{"key":"1886_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1476-4598-4-42","volume":"4","author":"E Smith","year":"2005","unstructured":"Smith E, Drew PA, Tian ZQ, De Young NJ, Liu JF, Mayne GC, Ruszkiewicz AR, Watson DI, Jamieson GG: Metallothionien 3 expression is frequently down-regulated in oesophageal squamous cell carcinoma by DNA methylation. Mol Cancer. 2005, 4: 42-","journal-title":"Mol Cancer"},{"key":"1886_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/carcin\/24.1.25","volume":"24","author":"D Deng","year":"2003","unstructured":"Deng D, El-Rifai W, Ji J, Zhu B, Trampont P, Li J, Smith MF, Powel SM: Hypermethylation of metallothionein-3 CpG island in gastric carcinoma. Carcinogenesis. 2003, 24: 25-29.","journal-title":"Carcinogenesis"},{"key":"1886_CR27","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1093\/nar\/24.24.5064","volume":"24","author":"A Olek","year":"1996","unstructured":"Olek A, Oswald J, Walter J: A modified and improved method for bisulphite based cytosine methylation analysis. Nucleic Acids Res. 1996, 24: 5064-5066.","journal-title":"Nucleic Acids Res"},{"key":"1886_CR28","doi-asserted-by":"publisher","first-page":"6516","DOI":"10.1158\/0008-5472.CAN-09-4566","volume":"70","author":"Y Cheng","year":"2010","unstructured":"Cheng Y, Geng H, Cheng SH, Liang P, Bai Y, Li J, Srivastava G, Ng MH, Fukagawa T, Wu X, Chan AT, Tao Q: KRAB zinc finger protein ZNF382 is a proapoptotic tumor suppressor that represses multiple oncogenes and is commonly silenced in multiple carcinomas. Cancer Res. 2010, 70: 6516-6526.","journal-title":"Cancer Res"},{"key":"1886_CR29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1471-2350-14-74","volume":"14","author":"T Yan-Fang","year":"2013","unstructured":"Yan-Fang T, Jian N, Jun L, Na W, Pei-Fang X, Wen-Li Z, Dong W, Li P, Jian W, Xing F, Jian P: The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML). BMC medical genetics. 2013, 14: 74-","journal-title":"BMC medical genetics"},{"key":"1886_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1756-8722-4-20","volume":"4","author":"P Jian","year":"2011","unstructured":"Jian P, Li ZW, Fang TY, Jian W, Zhuan Z, Mei LX, Yan WS, Jian N: Retinoic acid induces HL-60 cell differentiation via the upregulation of miR-663. J Hematol Oncol. 2011, 4: 20-","journal-title":"J Hematol Oncol"},{"key":"1886_CR31","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/pros.22697","volume":"73","author":"HH Juang","year":"2013","unstructured":"Juang HH, Chung LC, Sung HC, Feng TH, Lee YH, Chang PL, Tsui KH: Metallothionein 3: an androgen-upregulated gene enhances cell invasion and tumorigenesis of prostate carcinoma cells. Prostate. 2013, 73: 1495-1506.","journal-title":"Prostate"},{"key":"1886_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1475-2867-12-40","volume":"12","author":"T Yan-Fang","year":"2012","unstructured":"Yan-Fang T, Dong W, Li P, Wen-Li Z, Jun L, Na W, Jian W, Xing F, Yan-Hong L, Jian N, Jian P: Analyzing the gene expression profile of pediatric acute myeloid leukemia with real-time PCR arrays. Cancer Cell Int. 2012, 12: 40-","journal-title":"Cancer Cell Int"},{"key":"1886_CR33","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1186\/1471-2407-12-619","volume":"12","author":"YF Tao","year":"2012","unstructured":"Tao YF, Lu J, Du XJ, Sun LC, Zhao X, Peng L, Cao L, Xiao PF, Pang L, Wu D, Wang N, Feng X, Li YH, Ni J, Wang J, Pan J: Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells. BMC Cancer. 2012, 12: 619-","journal-title":"BMC Cancer"},{"key":"1886_CR34","first-page":"1978","volume":"2011","author":"X Zhang","year":"1813","unstructured":"Zhang X, Tang N, Hadden TJ, Rishi AK: Akt, FoxO and regulation of apoptosis. Biochim Biophys Acta. 1813, 2011: 1978-1986.","journal-title":"Biochim Biophys Acta"},{"key":"1886_CR35","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.2174\/138945011796150280","volume":"12","author":"H Lu","year":"2011","unstructured":"Lu H, Huang H: FOXO1: a potential target for human diseases. Curr Drug Targets. 2011, 12: 1235-1244.","journal-title":"Curr Drug Targets"},{"key":"1886_CR36","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.2174\/138945011796150307","volume":"12","author":"M Monsalve","year":"2011","unstructured":"Monsalve M, Olmos Y: The complex biology of FOXO. Curr Drug Targets. 2011, 12: 1322-1350.","journal-title":"Curr Drug Targets"},{"key":"1886_CR37","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1038\/onc.2008.24","volume":"27","author":"Z Fu","year":"2008","unstructured":"Fu Z, Tindall DJ: FOXOs, cancer and regulation of apoptosis. Oncogene. 2008, 27: 2312-2319.","journal-title":"Oncogene"},{"key":"1886_CR38","doi-asserted-by":"publisher","first-page":"47928","DOI":"10.1074\/jbc.M207509200","volume":"277","author":"V Modur","year":"2002","unstructured":"Modur V, Nagarajan R, Evers BM, Milbrandt J: FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer. J Biol Chem. 2002, 277: 47928-47937.","journal-title":"J Biol Chem"},{"key":"1886_CR39","doi-asserted-by":"publisher","first-page":"8969","DOI":"10.1128\/MCB.20.23.8969-8982.2000","volume":"20","author":"N Nakamura","year":"2000","unstructured":"Nakamura N, Ramaswamy S, Vazquez F, Signoretti S, Loda M, Sellers WR: Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol Cell Biol. 2000, 20: 8969-8982.","journal-title":"Mol Cell Biol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-12-182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T04:41:33Z","timestamp":1630557693000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/1479-5876-12-182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,25]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1886"],"URL":"https:\/\/doi.org\/10.1186\/1479-5876-12-182","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,25]]},"assertion":[{"value":"29 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"182"}}